ScreenerHero
VTRVentas, Inc.
NYSE · US · Real Estate · REIT - Healthcare Facilities · ventasreit.com
89.30USD+0.28%Mkt Cap: 43.41B $P/E: 162.36

Ventas, Inc. is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United King…

Industry Peers

REIT - Healthcare Facilities
Screen all
vs REIT - Healthcare Facilities
P/E
Pricier
P/B
Pricier
Div Yield
Higher
1M Perf
Lower
WELL
Welltower Inc.
$160.76BUSDP/E 110.0
DOC
Healthpeak Properties, Inc.
$15.08BUSDP/E 68.3
OHI
Omega Healthcare Investors, Inc.
$15.00BUSDP/E 23.2
CTRE
CareTrust REIT, Inc.
$9.56BUSDP/E 25.6
HR
Healthcare Realty Trust Incorporated
$7.24BUSD
AED
Aedifica SA
$6.52BUSDP/E 6.3
CSH-UN
Chartwell Retirement Residences
$5.32BUSDP/E Infinity
SBRA
Sabra Health Care REIT, Inc.
$4.92BUSDP/E 31.0
NHI
National Health Investors, Inc.
$3.76BUSDP/E 25.0
COFB
Cofinimmo SA
$3.50BUSDP/E 15.9
PHP
Primary Health Properties PLC
$3.22BUSDP/E 13.8
MPT
Medical Properties Trust, Inc.
$2.76BUSD
DHC
Diversified Healthcare Trust
$2.33BUSD
LTC
LTC Properties, Inc.
$1.97BUSDP/E 15.1
SILA
Sila Realty Trust, Inc.
$1.68BUSDP/E 44.6
NHP
National Healthcare Properties, Inc.
$1.08BUSD
CPINV
Care Property Invest
$578.96MUSDP/E 8.3
UHT
Universal Health Realty Income Trust
$608.86MUSDP/E 34.3
CHCT
Community Healthcare Trust Incorporated
$528.29MUSDP/E 154.1
XRN
Chiron Real Estate Inc.
$497.10MUSD
STRW
Strawberry Fields REIT, Inc.
$182.60MUSDP/E 21.3
Indicators:|

Key Statistics

Company
Market Cap43.41B $
Enterprise Value56.29B $
Revenue (TTM)6.11B $
Gross Profit2.41B $
Net Income (TTM)251.38M $
Revenue/Share13.17 USD
Last Price89.30 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees542
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS92276F1003
Valuation
P/E (Trailing)162.36
P/E (Forward)105.18
PEG1.72
EV/EBITDA24.60
EV/Revenue9.21
P/S7.08
P/B3.30
EPS (TTM)0.55
EPS (Forward)0.85
52W Range
61.7694% of range91.06
52W High91.06 USD
52W Low61.76 USD
Profitability
Gross Margin41.38%
Oper. Margin13.77%
EBITDA Margin37.44%
Profit Margin4.31%
ROE2.01%
ROA0.91%
Growth
Revenue Growth21.90%
Earnings Growth10.00%
Cash Flow & Leverage
Operating CF1.65B $
CapEx (TTM)644.62M $
FCF Margin24.26%
FCF Yield3.42%
Net Debt12.54B $
Net Debt/EBITDA5.48
Balance Sheet
Debt/Equity1.06
Current Ratio0.21
Quick Ratio0.19
Book Value/Sh27.00 USD
Cash/Share0.3780 USD
Dividends
Fwd Div Rate2.000 USD
Trail. Div Rate1.960 USD
Div. Yield2.25%
5Y Avg Yield3.31%
Payout Ratio356.36%
Ex-Div DateJun 30, 2026
Pay DateJul 16, 2026
Splits
Last Split8757:10000
Split DateAug 18, 2015
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)96.57 USD
Upside (mean)+8.1%
Target Range86.00 USD – 110.00 USD
$86.00+8.1% to mean$110.00
# Analysts21
Ownership
Shares Out.486.17M
Float483.69M
Insiders0.53%
Institutions106.91%
Short Interest
Short Ratio6.0d
Short % Float5.46%
Short % Out.4.72%
Shares Short22.96M
Short (prev mo.)22.11M
Technical
SMA 5085.32 (+4.7%)
SMA 20079.78 (+11.9%)
Beta0.73
S&P 52W Chg18.52%
Avg Vol (30d)2.91M
Avg Vol (10d)4.61M
Technical Indicators
RSI (14)63.5
MACD0.6897
MACD Signal-0.1697
MACD Hist.+0.8594
BB Upper89.44 USD
BB Middle83.50 USD
BB Lower77.57 USD
BB Width14.22%
ATR (14)2.063 USD
Vol Ratio (20d)1.05x